News
12-13-2022, 01:48 PM
New research from cancer research and treatment organization City of Hope in the December 2022 issue of JNCCN-;Journal of the National Comprehensive Cancer Network finds that only 30% of patients with advanced neuroendocrine tumors (NETs) say their top goal for treatment is living longer.
More... (https://www.news-medical.net/news/20221212/Patients-and-doctors-agree-on-treatment-goals-only-half-the-time-according-to-JNCCN-study-on-people-with-neuroendocrine-tumors.aspx)
More... (https://www.news-medical.net/news/20221212/Patients-and-doctors-agree-on-treatment-goals-only-half-the-time-according-to-JNCCN-study-on-people-with-neuroendocrine-tumors.aspx)